Filter
406
Text search:
DST
Featured
56
131
Language
Document type
314
30
22
11
10
8
5
5
1
Countries / Regions
32
25
17
12
12
9
8
8
8
6
6
6
6
6
6
5
5
5
5
5
5
5
5
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
184
45
5
5
4
1
1
Toolboxes
251
20
7
7
4
3
3
3
2
2
2
1
1
1
1
1
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
(updated December 2014).
(Mise à jour décembre 2014)
Training for staff working at DR-TB management centres.
Training modules
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
Information note
Accessed November 2017.
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
Annex 1: Measuring progress towards targets
Annex 2: Modelling the impact of the 90-(90)-90 strategy
Annex 3: Investment packages by country setting
Annex 4: Country strategies
Annex 5: Strategic frameworks for research and development for new tools
Annex 6 : Estimating the cost of the 90-(90)-
...
Policy and Manual
